ABVEF (ABVEF) Stock Price & Analysis
ABVEF (ABVEF) rose 63.01% to USD 0.12 as of June 10, 2026 at 05:13 UTC, according to Nexqual real-time market data.
ABVEF last closed at USD 0.07; the session ranged USD 0.06–0.13 on volume of 437,562 shares. Market capitalization is $6.09M, with a 52-week range of USD 0–6.56 (PNK). Source: Nexqual, June 10, 2026 at 05:13 UTC.
Key Statistics (as of June 10, 2026 at 05:13 UTC)
| Price | USD 0.12 |
|---|---|
| Change | ▲ 63.01% (up) |
| Previous Close | USD 0.07 |
| Open | USD 0.11 |
| Day Range | USD 0.06 – 0.13 |
| 52-Week Range | USD 0 – 6.56 |
| Volume | 437,562 shares |
| Market Cap | $6.09M |
| Exchange | PNK |
Technical Analysis (ABVEF)
Nexqual's technical model rates ABVEF "SELL" based on 2 bullish and 5 bearish signals across 123 daily candles, as of June 10, 2026 at 05:13 UTC.
| Overall Signal | SELL |
|---|---|
| RSI (14) | 29.65 (oversold) |
| vs SMA50 | Below (USD 0.6) |
| MACD | -0.15 (negative) |
Analyst Ratings (ABVEF)
Wall Street analysts rate ABVEF "None", per Nexqual as of June 10, 2026 at 05:13 UTC.
| Consensus Rating | None |
|---|
Earnings (ABVEF)
Source: Nexqual, June 10, 2026 at 05:13 UTC.
Financials & Fundamentals (ABVEF)
| Total Revenue | $294.84M |
|---|---|
| Revenue Growth (YoY) | -45.00% |
| Gross Margin | -2.76% |
| Operating Margin | -23.25% |
| Profit Margin | -23.36% |
| Current Ratio | 0.23 |
| Total Cash | $664,430 |
| Total Debt | $133.84M |
Source: Nexqual, June 10, 2026 at 05:13 UTC.
Financial Health Score (ABVEF)
Nexqual rates ABVEF's overall financial health "Weak" across five dimensions, as of June 10, 2026 at 05:13 UTC.
| Growth | Critical — Revenue -45% YoY (latest Q), sharp decline |
|---|---|
| Profitability | Critical — Gross margin -3%, operating -23% |
| Balance Sheet | Mixed — $664K cash vs $134M debt |
| Cash Flow | Weak — Operating cash flow -$9M |
| Efficiency | Mixed — No data |
Ownership (ABVEF)
| Insider Ownership | +5.35% |
|---|---|
| Institutional Ownership | +15.88% |
| Shares Outstanding | 51.19M |
| Float | 23.89M |
Source: Nexqual, June 10, 2026 at 05:13 UTC.
Leadership (ABVEF)
ABVEF is led by Lionel Kambeitz (age 71), Co-Founder, Executive Chairman, CEO & President, per Nexqual as of June 10, 2026 at 05:13 UTC.
| Co-Founder, Executive Chairman, CEO & President | Lionel Kambeitz (age 71) |
|---|---|
| Executive VP, Chief Financial Officer & Director | Jason Zhao (age 41) |
Major Backers & Investors (ABVEF)
Notable institutional backers of ABVEF include Renaissance Technologies, Morgan Stanley, HRT Financial LP, according to Nexqual as of June 10, 2026 at 05:13 UTC.
Active Investors
| Investor | Stake |
|---|---|
| Renaissance Technologies | 2.92% |
| Morgan Stanley | 1.76% |
| HRT Financial LP | 1.04% |
| UBS Group AG | 0.55% |
| Citigroup Inc. | 0.41% |
| Susquehanna International Group, LLP | 0.38% |
| GM Advisory Group, LLC | 0.23% |
| Engineers Gate Manager Lp | 0.23% |
Source: Nexqual, June 10, 2026 at 05:13 UTC.
Peers & Related Stocks
| Symbol | Name | Price | Change |
|---|---|---|---|
| BTOG | Bit Origin Limited | USD 1.69 | ▲ 3.68% |
| BSLK | Bolt Projects Holdings, Inc. | USD 0.05 | ▼ 24.64% |
| GRML | Greenland Mines Ltd | USD 0.3 | ▼ 2.61% |
| PLRZ | Polyrizon Ltd. | USD 11.45 | ▼ 11.86% |
| PROK | ProKidney Corp. | USD 1.67 | ▼ 7.22% |
Data source: Nexqual — real-time market data, technical indicators, analyst consensus, earnings, SEC EDGAR filings. Last updated: June 10, 2026 at 05:13 UTC. This page is informational and not investment advice.